Stewart-Bluefarb syndrome: review of the literature and case report of chronic ulcer treatment with heparan sulphate (Cacipliq20®)

Heparin/heparan sulphate-based drugs

(2010) Neha S. Gandhi et al.   DRUG DISCOVERY TODAY

Synthetic Heparan Sulfate Oligosaccharides Inhibit Endothelial Cell Functions Essential for Angiogenesis

(2010) Claire L. Cole et al.   PLoS One

Regenerating matrix-based therapy for chronic wound healing: a prospective within-subject pilot study

(2010) Suzanne L Groah et al.   International Wound Journal

Stewart-Bluefarb syndrome: A case report with angiographic findings

(2009) Bengu Gerceker TURK et al.   JOURNAL OF DERMATOLOGY

Stimulated neovascularization, inflammation resolution and collagen maturation in healing rat cutaneous wounds by a heparan sulfate glycosaminoglycan mimetic, OTR4120

(2009) Miao Tong et al.   WOUND REPAIR AND REGENERATION

The Structure of Glycosaminoglycans and their Interactions with Proteins

(2008) Neha S. Gandhi et al.   Chemical Biology & Drug Design

Matrix therapy in regenerative medicine, a new approach to chronic wound healing

(2008) V. Barbier-Chassefière et al.   JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A

Significant reduction in neural adhesions after administration of the regenerating agent OTR4120, a synthetic glycosaminoglycan mimetic, after peripheral nerve injury in rats

(2008) H. Mischa Zuijdendorp et al.   JOURNAL OF NEUROSURGERY